[go: up one dir, main page]

TW231970B - - Google Patents

Info

Publication number
TW231970B
TW231970B TW082103742A TW82103742A TW231970B TW 231970 B TW231970 B TW 231970B TW 082103742 A TW082103742 A TW 082103742A TW 82103742 A TW82103742 A TW 82103742A TW 231970 B TW231970 B TW 231970B
Authority
TW
Taiwan
Prior art keywords
pct
sec
date
date dec
pub
Prior art date
Application number
TW082103742A
Other languages
English (en)
Original Assignee
Glaxo Lab Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Lab Sa filed Critical Glaxo Lab Sa
Application granted granted Critical
Publication of TW231970B publication Critical patent/TW231970B/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
TW082103742A 1992-05-07 1993-05-12 TW231970B (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929209882A GB9209882D0 (en) 1992-05-07 1992-05-07 Compositions

Publications (1)

Publication Number Publication Date
TW231970B true TW231970B (zh) 1994-10-11

Family

ID=10715158

Family Applications (1)

Application Number Title Priority Date Filing Date
TW082103742A TW231970B (zh) 1992-05-07 1993-05-12

Country Status (33)

Country Link
US (1) US5705506A (zh)
EP (1) EP0639072B1 (zh)
JP (1) JPH07506570A (zh)
KR (1) KR100253111B1 (zh)
AT (1) ATE163850T1 (zh)
AU (1) AU670083B2 (zh)
BE (1) BE1007024A5 (zh)
BG (1) BG62120B1 (zh)
BR (1) BR1100108A (zh)
CA (1) CA2135179C (zh)
CH (1) CH685920A5 (zh)
CY (1) CY2039B1 (zh)
CZ (1) CZ283512B6 (zh)
DE (1) DE69317418T2 (zh)
ES (1) ES2113533T3 (zh)
FR (1) FR2690847B1 (zh)
GB (2) GB9209882D0 (zh)
GR (1) GR3026584T3 (zh)
HK (1) HK95697A (zh)
HU (2) HU227338B1 (zh)
IE (1) IE75203B1 (zh)
IL (1) IL105468A (zh)
IT (1) IT1261471B (zh)
NO (1) NO306700B1 (zh)
NZ (1) NZ252132A (zh)
OA (1) OA10109A (zh)
RO (1) RO112993B1 (zh)
RU (1) RU2118527C1 (zh)
SG (1) SG46649A1 (zh)
TW (1) TW231970B (zh)
UA (1) UA37206C2 (zh)
WO (1) WO1993021916A1 (zh)
ZA (1) ZA933178B (zh)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2434297A (en) * 1996-05-23 1997-12-09 Alcon Laboratories, Inc. The use of 5-ht1b/1d agonists to treat ocular pain
US7189753B1 (en) 1997-11-06 2007-03-13 Cady Roger K Preemptive prophylaxis of migraine
TR200002771T2 (tr) * 1998-03-26 2001-02-21 Fujisawa Pharmaceutical Co.,Ltd. Devamlı salımı olan preparatlar
AU3731400A (en) * 1999-03-05 2000-09-21 Trustees Of University Technology Corporation, The Methods and compositions useful in inhibiting apoptosis
AR056690A1 (es) * 2005-10-14 2007-10-17 Athersys Inc Derivados de indol como inhibidores de indol como inhibidores del receptor 3 de histamina para el tartamiento de trastornos del sueno y cognitivos obesidad y otros trastornos de snc
SI2124556T1 (sl) 2006-10-09 2015-01-30 Charleston Laboratories, Inc. Farmacevtske sestave
JP5714910B2 (ja) 2008-01-09 2015-05-07 チャールストン ラボラトリーズ，インコーポレイテッド 薬学的組成物
WO2011006012A1 (en) 2009-07-08 2011-01-13 Charleston Laboratories Inc. Pharmaceutical compositions
US9186359B2 (en) 2010-10-15 2015-11-17 Contera Pharma Aps Combinations of serotonin receptor agonists for treatment of movement disorders
SG11201406690SA (en) 2012-04-18 2014-11-27 Contera Pharma Aps Orally available pharmaceutical formulation suitable for improved management of movement disorders
WO2017152130A1 (en) 2016-03-04 2017-09-08 Charleston Laboratories, Inc. Pharmaceutical compositions
WO2018011181A1 (en) 2016-07-11 2018-01-18 Contera Pharma Aps Pulsatile drug delivery system for treating morning akinesia

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2082175B (en) * 1980-08-12 1984-05-02 Glaxo Group Ltd Heterocyclic compounds
GB2083463B (en) * 1980-08-12 1984-05-10 Glaxo Group Ltd Heterocyclic compounds
ZW19381A1 (en) * 1980-08-12 1983-03-09 Glaxo Group Ltd Heterocyclic compounds
IT1170387B (it) * 1982-06-07 1987-06-03 Glaxo Group Ltd Composti eterociclici, procedimento per prepararli e composizioni farmaceutiche che li contengono
GB8332435D0 (en) * 1983-12-06 1984-01-11 Glaxo Group Ltd Chemical compounds
GB2162522B (en) * 1984-08-01 1988-02-24 Glaxo Group Ltd An indole derivative
GB8419575D0 (en) * 1984-08-01 1984-09-05 Glaxo Group Ltd Chemical compounds
FR2574077A1 (fr) * 1984-12-04 1986-06-06 Glaxo Group Ltd Derives d'indoles, leur preparation et les compositions pharmaceutiques les contenant
GB8431426D0 (en) * 1984-12-13 1985-01-23 Glaxo Group Ltd Chemical compounds
DE3678805D1 (de) * 1985-11-08 1991-05-23 Glaxo Group Ltd Indolderivate.
KR0131327B1 (en) * 1987-08-13 1998-04-17 Glaxo Group Ltd Indole derivatives
MC2210A1 (fr) * 1990-06-07 1992-11-26 Wellcome Found Composes heterocycliques therapeutiques,leur utilisation et procede pour les preparer

Also Published As

Publication number Publication date
OA10109A (en) 1996-12-18
EP0639072A1 (en) 1995-02-22
ITRM930286A0 (it) 1993-05-06
NO944214L (no) 1994-11-07
DE69317418D1 (de) 1998-04-16
GB9209882D0 (en) 1992-06-24
NO944214D0 (no) 1994-11-04
RU2118527C1 (ru) 1998-09-10
NO306700B1 (no) 1999-12-13
BR1100108A (pt) 1999-12-07
US5705506A (en) 1998-01-06
GR3026584T3 (en) 1998-07-31
HUT71418A (en) 1995-11-28
ATE163850T1 (de) 1998-03-15
SG46649A1 (en) 1998-02-20
BG99167A (bg) 1995-06-30
CZ283512B6 (cs) 1998-04-15
UA37206C2 (uk) 2001-05-15
DE69317418T2 (de) 1998-07-30
KR100253111B1 (en) 2000-07-01
BE1007024A5 (fr) 1995-02-21
ES2113533T3 (es) 1998-05-01
IT1261471B (it) 1996-05-23
IL105468A (en) 1998-09-24
GB2266665B (en) 1996-05-22
ZA933178B (en) 1994-01-10
WO1993021916A1 (en) 1993-11-11
EP0639072B1 (en) 1998-03-11
GB2266665A (en) 1993-11-10
CA2135179C (en) 2000-12-05
HU227338B1 (en) 2011-04-28
AU670083B2 (en) 1996-07-04
AU4064093A (en) 1993-11-29
CZ272394A3 (en) 1995-10-18
ITRM930286A1 (it) 1994-11-06
CH685920A5 (fr) 1995-11-15
NZ252132A (en) 1996-09-25
GB9309209D0 (en) 1993-06-16
FR2690847B1 (fr) 1995-06-09
JPH07506570A (ja) 1995-07-20
HK95697A (en) 1997-08-08
IE75203B1 (en) 1997-08-27
BG62120B1 (bg) 1999-03-31
CY2039B1 (en) 1998-04-30
IL105468A0 (en) 1993-08-18
FR2690847A1 (fr) 1993-11-12
RO112993B1 (ro) 1998-03-30
IE930339A1 (en) 1993-11-17
HU211638A9 (en) 1995-12-28
CA2135179A1 (en) 1993-11-11

Similar Documents

Publication Publication Date Title
MX9702865A (es) Agentes estrogenicos.
IL127244A (en) Substituted amines, methods of their preparation and pharmaceutical compositions containing them
BG105534A (en) 5ht1 means and method for the treatment of migraine
EP0903349A3 (en) CCR-3 receptor antagonists
ES2160949T3 (es) Derivados de fenilen-sulfonamida sustituidos en meta.
MX9301032A (es) Compuestos farmaceuticos y procedimento para su preparacion
CA2366268A1 (en) Pharmaceutical compositions for cns and other disorders
DK0641328T3 (da) Broforbundne, azabicykliske derivater som substans P-antagonister
BG105564A (en) Galantamine-containing composition with controlled release
GB2266665B (en) 5-HT1-like receptor agonist for rectal administration
ZA971279B (en) Use of 5ht4 receptor antagonists for overcoming gastrointestinal effects of serotonin reuptake inhinitors
MX9505064A (es) Composicion farmaceutica, aplicable oralmente.
MX9505065A (es) Composicion farmaceutica, aplicable oralmente.
GR3022615T3 (en) Pharmaceutical compositions based on ebastime or analogues thereof.
ZA922297B (en) Crystalline tiababine monohydrate,its preparation and use
WO2000000198A8 (en) Piperidine derivatives having effects on serotonin related systems
NO944781L (no) 2,5-diokso-2,5-dihydro-1H-benz(b)azepiner som NMDA-reseptor-antagonister
GR3036195T3 (en) Novel compounds
FR2724933B1 (zh)
HU9500175D0 (en) Pharmacologically active alpha-[tertiary-aminomethyl]-benzenemethanol derivatives
MY118946A (en) Novel intermediates and their use to prepare n, n''- bridged bisindolylmaleimides
ATE162946T1 (de) Pharmazeutische zusammensetzungen enthaltend contignasterol-verbindungen
DK1030659T3 (da) Farmaceutisk præparat indeholdende (+)-efedrin og en H1-receptor antagonist
UA30798A (uk) Спосіб пролонгованої терапії онкологічних хворих